.png){kind=small}
.png){kind=small}
This week on the
BackTable Tumor Board
BackTable Tumor Board is a multidisciplinary podcast for healthcare professionals that play an active role in cancer care. Our first season features in-depth conversations on the topic of hepatocellular carcinoma (HCC) provided by a group of medical oncologists, interventional radiologists, hepatobiliary surgeons, hepatologists, and patient coordinators. Stay tuned for the next season!
Follow:
Subscribe:
Sign Up:
Featured Podcast
Tumor Board Episode #5
Complex HCC Patients & The "Grey Zone": What To Do When You Don’t Know What To Do
with Dr. Adam Burgoyne, Dr. Zach Berman, Dr. Kirema Garcia-Reyes and Dr. Lingling Du
Treatment of hepatocellular carcinoma (HCC), like that of many other cancers, spans a spectrum from curative to palliative intent. To explore the "grey zone" of treatment goals for intermediate-stage HCC patients, Dr. Sabeen Dhand interviews a panel of experts in the field: medical oncologists Dr. Adam Burgoyne and Dr. Lingling Du, along with interventional radiologists Dr. Kirema Garcia-Reyes and Dr. Zachary Berman.
This podcast is supported by an educational grant from AstraZeneca Pharmaceuticals and Boston Scientific.
